Junichi Soh

7.4k citations

211 papers · 5.5k indexed · 1 hit paper · h-index 40

Impact in

Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Cancer Research top 1%
- Cancer Genomics and Diagnostics

Papers in ⓘ

Pulmonary and Respiratory Medicine 155
- Lung Cancer Treatments and Mutations 104
- Lung Cancer Diagnosis and Treatment 55
- Medical Imaging and Pathology Studies 15
Oncology 92
- Lung Cancer Research Studies 30
- HER2/EGFR in Cancer Research 23
- Colorectal Cancer Treatments and Studies 19

Co-authors: Shinichi Toyooka (164 shared papers)Hiromasa Yamamoto (97 shared papers)Shinichiro Miyoshi (90 shared papers)Katsuyuki Kiura (50 shared papers)Hiroaki Asano (44 shared papers)Hiroshi Date (32 shared papers)Kazuhiko Shien (73 shared papers)Adi F. Gazdar (13 shared papers)
Journals: Journal of Thoracic Oncology (18 papers)Cancer Research (16 papers)Lung Cancer (15 papers)Surgery Today (12 papers)Cancer Science (9 papers)
Partner nations: Japan United States Canada

In The Last Decade

Junichi Soh

201 papers receiving 5.4k citations

Hit Papers

align trajectories log scale

KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments 2021 · 167 citations

Peers

Countries citing papers authored by Junichi Soh

Since Specialization

Citations

This map shows the geographic impact of Junichi Soh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichi Soh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichi Soh more than expected).

Fields of papers citing papers by Junichi Soh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichi Soh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichi Soh. The network helps show where Junichi Soh may publish in the future.

Co-authors

The 25 scholars most cited alongside Junichi Soh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Junichi Soh Line = papers co-authored together Junichi Soh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 211 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Presence ofEpidermal Growth Factor ReceptorGene T790M Mutation as a Minor Clone in Non–Small Cell Lung Cancer Cancer Research ·Michio Inukai, Shinichi Toyooka, Sachio Ito, Hiroaki Asano, Shuji Ichihara, Junichi Soh, Hiroshi Suehisa, Mamoru Ouchida, Keisuke Aoe, Motoi Aoe, Katsuyuki Kiura, Nobuyoshi Shimizu, Hiroshi Date	2006	355
2	PIK3CA Mutations and Copy Number Gains in Human Lung Cancers Cancer Research ·Hiromasa Yamamoto, Hisayuki Shigematsu, Masaharu Nomura, William W. Lockwood, Mitsuo Sato, Naoki Okumura, Junichi Soh, Makoto Suzuki, Ignacio I. Wistuba, Kwun M. Fong, Huei Lee, Shinichi Toyooka, Hiroshi Date, Wan L. Lam, John D. Minna, Adi F. Gazdar	2008	340
3	Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell–like Properties in Cancer Cells Cancer Research ·Kazuhiko Shien, Shinichi Toyooka, Hiromasa Yamamoto, Junichi Soh, Masaru Jida, Kelsie L. Thu, Shinsuke Hashida, Yuho Maki, Eiki Ichihara, Hiroaki Asano, Kazunori Tsukuda, Nagio Takigawa, Katsuyuki Kiura, Adi F. Gazdar, Wan L. Lam, Shinichiro Miyoshi	2013	223
4	Genetic Predictors of MEK Dependence in Non–Small Cell Lung Cancer Cancer Research ·Christine A. Pratilas, Aphrothiti J. Hanrahan, Ensar Halilovic, Yogindra Persaud, Junichi Soh, Dhananjay Chitale, Hisayuki Shigematsu, Hiromasa Yamamoto, Ayana Sawai, Manickam Janakiraman, Barry S. Taylor, William Pao, Shinichi Toyooka, Marc Ladanyi, Adi F. Gazdar, Neal Rosen, David B. Solit	2008	195
5	Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells PLoS ONE ·Junichi Soh, Naoki Okumura, William W. Lockwood, Hiromasa Yamamoto, Hisayuki Shigematsu, Wei Zhang, Raj Chari, David S. Shames, Ximing Tang, Calum MacAulay, Marileila Varella‐Garcia, Tõnu Vooder, Ignacio I. Wistuba, Stephen Lam, Rolf A. Brekken, Shinichi Toyooka, John D. Minna, Wan L. Lam, Adi F. Gazdar	2009	179
6	Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines PLoS ONE ·Jeet Gandhi, Jianling Zhang, Yang Xie, Junichi Soh, Hisayuki Shigematsu, Wei Zhang, Hiromasa Yamamoto, Michael Peyton, Luc Girard, William W. Lockwood, Wan L. Lam, Marileila Varella‐Garcia, John D. Minna, Adi F. Gazdar	2009	169
7	KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments Journal of Thoracic Oncology ·T. Koga, Kenichi Suda, Toshio Fujino, Shuta Ohara, Akira Hamada, Masaya Nishino, Masato Chiba, Masaki Shimoji, Toshiki Takemoto, Takeo Arita, Michael Gmachl, Marco H. Hofmann, Junichi Soh, Tetsuya Mitsudomi Hit paper breakdown →	2021	167
8	Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy Molecular Cancer Therapeutics ·Noriaki Sunaga, David S. Shames, Luc Girard, Michael Peyton, Jill E. Larsen, Hisao Imai, Junichi Soh, Mitsuo Sato, Noriko Yanagitani, Kyoichi Kaira, Yang Xie, Adi F. Gazdar, Masatomo Mori, John D. Minna	2011	135
9	MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors International Journal of Cancer ·Takafumi Kubo, Hiromasa Yamamoto, William W. Lockwood, Ilse Valencia, Junichi Soh, Michael Peyton, Masaru Jida, Hiroki Otani, Tetsuya Fujii, Mamoru Ouchida, Nagio Takigawa, Katsuyuki Kiura, Kenji Shimizu, Hiroshi Date, John D. Minna, Marileila Varella‐Garcia, Wan L. Lam, Adi F. Gazdar, Shinichi Toyooka	2008	117
10	Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations Journal of Thoracic Oncology ·Adi Gazdar, Linda Robinson, Dwight Oliver, Chao Xing, William D. Travis, Junichi Soh, Shinichi Toyooka, Lori Watumull, Yang Xie, Kemp H. Kernstine, Joan H. Schiller	2014	106
11	The impact of epidermal growth factor receptor gene status on gefitinib‐treated Japanese patients with non‐small‐cell lung cancer International Journal of Cancer ·Shuji Ichihara, Shinichi Toyooka, Yoshiro Fujiwara, Katsuyuki Hotta, Hisayuki Shigematsu, Masaki Tokumo, Junichi Soh, Hiroaki Asano, Kouichi Ichimura, Keisuke Aoe, Motoi Aoe, Katsuyuki Kiura, Kenji Shimizu, Hiroshi Date, Nobuyoshi Shimizu	2006	101
12	Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer Lung Cancer ·Norimitsu Tanaka, Shinichi Toyooka, Junichi Soh, Takafumi Kubo, Hiromasa Yamamoto, Yuho Maki, Takayuki Muraoka, Kazuhiko Shien, Masashi Furukawa, Tsuyoshi Ueno, Hiroaki Asano, Kazunori Tsukuda, Keisuke Aoe, Shinichiro Miyoshi	2011	98
13	Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer International Journal of Cancer ·Junichi Soh, Shinichi Toyooka, Keisuke Aoe, Hiroaki Asano, Syuji Ichihara, Hideki Katayama, Akio Hiraki, Katsuyuki Kiura, Motoi Aoe, Yoshifumi Sano, Kazuro Sugi, Nobuyoshi Shimizu, Hiroshi Date	2006	94
14	Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma Clinical Cancer Research ·Takafumi Kubo, Shinichi Toyooka, Kazunori Tsukuda, Masakiyo Sakaguchi, Takuya Fukazawa, Junichi Soh, Hiroaki Asano, Tsuyoshi Ueno, Takayuki Muraoka, Hiromasa Yamamoto, Yasutomo Nasu, Takumi Kishimoto, Harvey I. Pass, Hideki Matsui, Nam‐ho Huh, Shinichiro Miyoshi	2011	92
15	Novel Germline Mutation in the Transmembrane Domain of HER2 in Familial Lung Adenocarcinomas JNCI Journal of the National Cancer Institute ·Hiromasa Yamamoto, Koichiro Higasa, Masakiyo Sakaguchi, Kazuhiko Shien, Junichi Soh, Koichi Ichimura, Masashi Furukawa, Shinsuke Hashida, Kazunori Tsukuda, Nagio Takigawa, Keitaro Matsuo, Katsuyuki Kiura, Shinichiro Miyoshi, Fumihiko Matsuda, Shinichi Toyooka	2013	88
16	Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy Lung Cancer ·Kazuhiko Shien, Shinichi Toyooka, Kouichi Ichimura, Junichi Soh, Masashi Furukawa, Yuho Maki, Takayuki Muraoka, Norimitsu Tanaka, Tsuyoshi Ueno, Hiroaki Asano, Kazunori Tsukuda, Masaomi Yamane, Takahiro Oto, Katsuyuki Kiura, Shinichiro Miyoshi	2012	81
17	The Impact of Sex and Smoking Status on the Mutational Spectrum of Epidermal Growth Factor Receptor Gene in Non–small Cell Lung Cancer Clinical Cancer Research ·Shinichi Toyooka, Keitaro Matsuo, Hisayuki Shigematsu, Takayuki Kosaka, Masaki Tokumo, Yasushi Yatabe, Syuji Ichihara, Michio Inukai, Hiroshi Suehisa, Junichi Soh, Katsuyuki Kiura, Kwun M. Fong, Huei Lee, Ignacio I. Wistuba, Adi F. Gazdar, Tetsuya Mitsudomi, Hiroshi Date	2007	76
18	CDKN2A/p16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non–Small-Cell Lung Cancer Journal of Thoracic Oncology ·Kit Tam, Wei Zhang, Junichi Soh, Victor Stastny, Min Chen, Han Sun, Kelsie L. Thu, Jonathan J. Rios, Chenchen Yang, Crystal N. Marconett, Suhaida A. Selamat, Ite A. Laird‐Offringa, Ayumu Taguchi, Samir Hanash, David S. Shames, Xiaotu Ma, Michael Q. Zhang, Wan L. Lam, Adi F. Gazdar	2013	74
19	Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR -Mutant Non–Small Cell Lung Cancer Cells Molecular Cancer Research ·Kei Namba, Kazuhiko Shien, Yuta Takahashi, Hidejiro Torigoe, Hiroki Sato, Takahiro Yoshioka, Tatsuaki Takeda, Eisuke Kurihara, Yusuke Ogoshi, Hiromasa Yamamoto, Junichi Soh, Shuta Tomida, Shinichi Toyooka	2018	71
20	ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer Lung Cancer ·Tetsuya Fujii, Shinichi Toyooka, Kouichi Ichimura, Yoshiro Fujiwara, Katsuyuki Hotta, Junichi Soh, Hiroshi Suehisa, Naruyuki Kobayashi, Motoi Aoe, Tadashi Yoshino, Katsuyuki Kiura, Hiroshi Date	2007	69

About Junichi Soh

Junichi Soh is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Microbiology and Internal Medicine, having authored 211 papers that have together received 5.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (104 papers), Lung Cancer Diagnosis and Treatment (55 papers), Lung Cancer Research Studies (30 papers), HER2/EGFR in Cancer Research (23 papers), Cancer Genomics and Diagnostics (23 papers), PI3K/AKT/mTOR signaling in cancer (20 papers), Colorectal Cancer Treatments and Studies (19 papers) and Medical Imaging and Pathology Studies (15 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.2k citations), Cancer Research (1.5k citations), Oncology (2.5k citations), Molecular Biology (2.5k citations) and Pathology and Forensic Medicine (410 citations). Junichi Soh has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Shinichi Toyooka, Hiromasa Yamamoto, Shinichiro Miyoshi, Katsuyuki Kiura, Hiroaki Asano, Hiroshi Date, Kazuhiko Shien, Adi F. Gazdar, Kazunori Tsukuda and Tetsuya Mitsudomi. Their work appears in journals such as Journal of Thoracic Oncology, Cancer Research, Lung Cancer, Surgery Today and Cancer Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact